文献速递乳腺癌放疗放疗物理与技术

咖啡酸苯乙酯在乳腺癌中的放射增敏作用依赖p53状态

The radiosensitizing effect of Caffeic Acid Phenethyl Ester in breast cancer is dependent on p53 status.
PubMed 文献 · Radiother Oncol · 2025-05-21

该研究在体外和体内探讨咖啡酸苯乙酯(CAPE)对乳腺癌的放射增敏及正常组织保护作用。CAPE以剂量依赖方式降低细胞活力,仅使p53突变或缺失的乳腺癌细胞系对放疗增敏,对p53功能正常的细胞系无增敏作用;在正常乳腺细胞中CAPE增加辐射后存活分数。体内MDA-MB-231荷瘤小鼠中,放疗联合CAPE较对照延长生存至22天。

要点

  • CAPE仅对p53突变或缺失的乳腺癌细胞系产生放射增敏作用。
  • CAPE在正常乳腺细胞中增加辐射后存活分数,具放射保护潜力。
  • CAPE使p53突变癌细胞NF-κB活性降低,而p53功能正常细胞中升高。

核心结论

  • CAPE可能通过放射增敏p53非功能性乳腺癌细胞并保护正常组织来拓宽治疗窗。

研究设计与样本

  • 体外采用luminal A、HER2+和三阴性乳腺癌及正常乳腺细胞系,以细胞活力与克隆存活实验评估细胞毒和放射增敏效应,并检测代谢、线粒体功能与炎症。
  • 体内采用MDA-MB-231荷瘤小鼠模型评估CAPE抗肿瘤作用。

主要发现

  • CAPE以剂量依赖方式降低细胞活力,IC50为53.5 ± 33.7 µM。
  • CAPE使细胞代谢向糖酵解偏移(p < 0.05)并诱导线粒体膜去极化(p < 0.01)。
  • CAPE仅使p53突变或缺失细胞系对放疗增敏(p < 0.05),对p53功能正常细胞系无增敏。
  • 正常乳腺细胞中CAPE增加辐射后存活分数(p = 0.03)。
  • CAPE处理后p53突变癌细胞NF-κB活性降低(p < 0.01),p53功能正常细胞系中升高(p < 0.01);放疗联合CAPE较对照延长生存至22天(p < 0.05)。

临床怎么用

  • 对p53突变或缺失的乳腺癌,CAPE可能作为放疗增敏剂与放疗联合使用。
  • CAPE对正常乳腺细胞具放射保护潜力,可能有助于拓宽治疗窗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Radiotherapy is one of the standard treatments for breast cancer, but causes adverse effects in normal tissues, narrowing the therapeutic window. Caffeic Acid Phenethyl Ester (CAPE) has been proposed to have cytotoxic and radiosensitizing effects in cancer cells, whilst protective properties in normal tissues. We have investigated the anti-tumour effects of CAPE in breast cancer in vitro and in vivo and provided evidence regarding its radioprotective effect. MATERIALS AND METHODS: Cytotoxic and radiosensitizing effects were determined in vitro in luminal A, HER2+ and triple negative breast cancer and in normal breast cell lines by cell viability and clonogenic survival assays, respectively. Effects on cell metabolism, mitochondrial function and inflammation were investigated. CAPE anti-tumour effects were also investigated in vivo in a MDA-MB-231 tumour-bearing mouse model. RESULTS: Cell viability decreased upon CAPE treatment in a dose dependent manner (IC50 53.5 ± 33.7 µM). CAPE shifted cellular metabolism towards glycolysis (p < 0.05) and induced mitochondrial membrane depolarization (p < 0.01). CAPE sensitized only p53 mutated or deficient cell lines to radiotherapy (p < 0.05), but not p53 proficient lines. In normal breast cells, CAPE increased the surviving fraction upon radiation (p = 0.03). NF-κB activity was decreased in p53 mutant cancer cells (p < 0.01), but increased in p53 proficient lines (p < 0.01) upon CAPE treatment. Combination of radiotherapy and CAPE resulted in increased survival (22 days) compared to control (p < 0.05). CONCLUSION: Our findings highlight that CAPE could widen the therapeutic window in breast cancer with non-functional p53, by radiosensitizing the tumour cells while protecting the normal tissue.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Prades-Sagarra È, Geurts FAP, Biemans R, et al. The radiosensitizing effect of Caffeic Acid Phenethyl Ester in breast cancer is dependent on p53 status. Radiother Oncol. 2025. PMID: 40409368. doi:10.1016/j.radonc.2025.110945

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。